Fifteen years ago, on this very podcast, one of us predicted that bonds would become a problem. It took a while — long enough that the prophet was more or less left for dead on the side of the road — but the warning has finally arrived, and now that it's here, we can't seem to stop talking about it. Bonds are in the news again, for all kinds of reasons, and almost none of them good. So in this episode, Brandon and Brantley go back to the argument we've been making for over a decade: for the job most people are trying to give bonds, cash value life insurance quietly does it better. Let's be precise about the claim first, because it's easy to hear this as "never buy bonds," and that isn't it. If you want the income a bond produces, buy the bond and collect the income — that's a perfectly good reason to own one. The trouble starts when bonds get sold as the safety buffer in a portfolio — the low-risk ballast that's supposed to hold steady while stocks wobble. That story worked for a specific reason, over a specific window, and that window has closed. What we get into: Why bonds ever looked "safe" in the first place. For several decades, interest rates fell, bond prices rose, and bonds earned a reputation as the dependable counterweight to stocks. That wasn't a law of nature — it was a tailwind. Most people were never told it was a tailwind, which is exactly why the reversal caught them off guard. The number that stops the conversation. We use Vanguard's total bond market fund because it has enough history to actually run the math. From January 1987 through December 2019 — 32 years — it compounded at about 5.93% a year with distributions reinvested. Great for the "boring buffer" role. From January 2020 to today? Roughly 0.62% a year. There is no five-year stretch in that entire prior 32-year run that performed this badly. Why 2021–2022 was genuinely different. For decades, when the stock market fell, it usually signaled a slowdown, which pushed rates down and lifted bonds — that's the whole mechanism behind the buffer. In 2021–2022 the opposite happened: stocks and bonds fell together while rates rose. We couldn't find a precedent for it going back to 1987. And 2022 stands as the worst year for the Bloomberg U.S. Aggregate Bond Index since the index began in 1976. How we got here — and why it isn't over. COVID-era stimulus put a surge of money into the system right as a supply-side shock choked off goods. More money chasing less stuff is the textbook recipe for inflation. The Fed bet it was "transitory," reacted slowly, and then had to hike hard. But the bond market sets its own terms too — if buyers don't believe a given yield covers where prices are headed, they simply don't buy, and yields have to climb until they do. The live math, right now. The 10-year Treasury is sitting near 4.8%, a level it hasn't seen in more than a year and a half, with a fair number of forecasters calling for it to cross 5% before year-end. If that happens, a rough cut of the numbers says you'd give up somewhere around $20 of market value on every $1,000 of Treasuries you're holding — a real problem if you were counting on selling, a non-event if you only ever wanted the income. What life insurance does that a bond can't. When rates rise, the cash value in a whole life or indexed universal life policy doesn't drop. There's no market-value markdown to absorb — and better still, rising yields tend to lift what these products pay: higher dividends on whole life, and higher cap rates, higher participation rates, or narrower spreads on IUL. You shed the price-reduction risk and pick up the upside of the same rate move that punishes bondholders. The reframe that matters most. Here's the part we haven't said clearly enough over the years: we've never argued for cash value life insurance on total return — not against stocks, not against bonds. We evaluate it on what you can actually extract from the dollars you put in, usually measured as income. The rate of return matters in the background, but the question we're really answering is "what will this reliably do for the plan," not "did it beat the index this year." The policy-loan worry, handled honestly. Most good whole life contracts use variable loan rates, so people reasonably ask whether rising rates make borrowing more expensive. Nominally, yes — but these things don't happen in a vacuum. The same rising rates that lift your loan cost also lift the dividend, so the net cost of borrowing may barely move. We even get into the history here: fixed loan rates plus a promise to keep paying full dividends is exactly what created the direct- vs. non-direct-recognition problem back in the 1970s and '80s, and why "lock in the low fixed rate" isn't the free lunch it sounds like. The honest framing we hold to on-air: this isn't a promise that whole life "beats" bonds on a spreadsheet, and it isn't a trade you time. Whole life can be a little slower to react than an index product; dividends and cap rates do move with the environment, and none of it is meant to replace every bond in a plan. What it is designed to do is take on the job bonds are supposed to do — hold their ground and produce dependable income — without the market-value risk. When rates are choppy and heading nowhere fast, that's a job worth giving to the right tool. Read the full write-up: Whole Life vs. Bonds: Your Portfolio's Rate-Hike Hedge — the duration math, the bond-fund-vs-cash-value comparison, and the policy-loan wrinkle, all in one place. Looking at a life insurance illustration and not sure it actually fits the role you need it to play? Don't let ChatGPT be the last word — it'll hand you a confident answer that's often just the "whole life is a rip-off" line scraped off the internet, and confidently wrong is still wrong. Tell us a little about your situation, or send over the illustration, and we'll give you a straight, honest read: what's right, what's wrong, and whether it's a good fit for you. No pitch, no pressure. Send us a message, or if you'd rather talk it through, book a call with us.
